Comparison of a multiple daily injection regimen with once-daily insulin glargine basal insulin and mealtime lispro, to continuous subcutaneous insulin infusion: A randomised, open, parallel study

被引：0
|
作者：
Bolli, GB
Capani, F
Home, PD
Kerr, D
Thomas, R
Torlone, E
Selam, JL
Sola-Gazagnes, A
Vitacolonna, E
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A107 / A108
页数：2
相关论文
共 50 条
  • [1] Comparison of a multiple daily injection regimen with once-daily insulin glargine basal insulin and mealtime lispro, to continuous subcutaneous insulin infusion: a randomized, open, parallel study
    Bolli, GB
    Capani, F
    Kerr, D
    Thomas, R
    Torlone, E
    Selam, JL
    Sola-Gazagnes, A
    Vitacolonna, E
    DIABETOLOGIA, 2004, 47 : A301 - A301
  • [2] Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes A randomized open parallel multicenter study
    Bolli, Geremia B.
    Kerr, David
    Thomas, Reena
    Torlone, Elisabetta
    Sola-Gazagnes, Agnes
    Vitacolonna, Ester
    Selam, Jean Louis
    Home, Philip D.
    DIABETES CARE, 2009, 32 (07) : 1170 - 1176
  • [3] Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type I diabetes: a randomized open parallel multicenter study (vol 32, pg 1170, 2009)
    Bolli, G. B.
    Kerr, D.
    Thomas, R.
    Torlone, E.
    Sola-Gazagnes, A.
    Vitacolonna, E.
    Selam, J. L.
    Home, P. D.
    DIABETES CARE, 2009, 32 (10) : 1944 - 1944
  • [4] Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study
    Soledad Ruiz-de-Adana, Maria
    Dominguez-Lopez, Marta-Elena
    Gonzalez-Molero, Inmaculada
    Machado, Alberto
    Martin, Victor
    Cardona, Isabel
    de-la-Higuera, Magdalena
    Tapia, Maria-Jose
    Soriguer, Federico
    Teresa Anarte, Maria
    Rojo-Martinez, Gemma
    MEDICINA CLINICA, 2016, 146 (06): : 239 - 246
  • [5] Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are better than traditional multiple daily insulin injection treatment.
    Lepore, G
    Dodesini, AR
    Nosari, I
    Trevisan, R
    DIABETOLOGIA, 2003, 46 : A6 - A6
  • [6] Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment
    Lepore, G
    Dodesini, AR
    Nosari, I
    Trevisan, R
    DIABETES CARE, 2003, 26 (04) : 1321 - 1322
  • [7] Effect of continuous subcutaneous insulin infusion vs multiple daily insulin injection with glargine as basal insulin:: An open parallel long-term study
    Lepore, G
    Dodesini, AR
    Nosari, I
    Trevisan, R
    DIABETES NUTRITION & METABOLISM, 2004, 17 (02) : 84 - 89
  • [8] Switch from continuous subcutaneous insulin infusion (CSII) with insulin lispro [Humalog®]to multiple daily injections (MDI) with insulin glargine (Lantus) and insulin lispro
    Bode, B
    Schleusener, D
    Strange, P
    DIABETES, 2003, 52 : A102 - A103
  • [9] Intensive insulin therapy with insulin lispro - A randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection
    Tsui, E
    Barnie, A
    Ross, S
    Parkes, R
    Zinman, B
    DIABETES CARE, 2001, 24 (10) : 1722 - 1727
  • [10] Beneficial effects of continuous subcutaneous insulin infusion and flexible multiple daily insulin regimen using insulin glargine in type 1 diabetes
    Alemzadeh, R
    Ellis, JN
    Holzum, MK
    Parton, EA
    Wyatt, DT
    PEDIATRICS, 2004, 114 (01) : E91 - E95
12345